Cargando…
The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis
BACKGROUND: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women of reproductive age, and it is estimated that up to a third of women will experience it at some point in their lives. BV produces an offensive vaginal odour and it is associated with serious sequelae. The mos...
Autores principales: | Haydock, Rebecca, Hepburn, Trish, Ross, Jonathan, Daniels, Jane, Brittain, Clare, Jackson, Louise, Ozolins, Mara, Wilson, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768774/ https://www.ncbi.nlm.nih.gov/pubmed/36544202 http://dx.doi.org/10.1186/s13063-022-06954-x |
Ejemplares similares
-
Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms
por: Gaspar, Carlos, et al.
Publicado: (2021) -
Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
por: Ross, Jonathan D. C., et al.
Publicado: (2023) -
Susceptibility testing of Atopobium vaginae for dequalinium chloride
por: Lopes dos Santos Santiago, Guido, et al.
Publicado: (2012) -
Dona y Deva
por: Silva, Pedro de 1945-
Publicado: (1995) -
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2019)